PCM
CRL icon

Polymer Capital Management’s Charles River Laboratories CRL Stock Holding History

Polymer Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,495
Closed -$703K – 805
2025
Q3 		$703K Buy
+4,495
New +$714K 0.07% 320

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Polymer Capital Management's CRL Position: Q4 2025 in Review

Polymer Capital Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 4,495 shares — an estimated $703K sold.

Polymer Capital Management first reported a position in CRL in Q3 2025 and held it in 1 quarter. The position peaked at $703K in Q3 2025. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Polymer Capital Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Polymer Capital Management sold 4,495 Charles River Laboratories shares in Q4 2025, an estimated $703K.
  • Polymer Capital Management first reported a position in Charles River Laboratories in Q3 2025 and held it in 1 quarter.
  • Polymer Capital Management's Charles River Laboratories position peaked at $703K in Q3 2025.
  • 581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Polymer Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.